We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current MEIP market cap is 18.66M. The company's latest EPS is USD 2.6682 and P/E is 1.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 65.3M | 0 | 0 | 0 | 0 |
| Operating Income | 55.28M | -11.93M | -9.83M | -8.08M | -8.35M |
| Net Income | 56.37M | -11.06M | -9.13M | -18.41M | -8.01M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.91M | 25.54M | 40.7M | 48.82M | 65.3M |
| Operating Income | -24.54M | -69.69M | -75.48M | -36.76M | 25.44M |
| Net Income | -46.02M | -50.58M | -54.45M | -31.84M | 17.78M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.25M | 78.54M | 71.26M | 41.38M | 27.75M |
| Total Liabilities | 19.89M | 19.05M | 20.23M | 8.36M | 2.87M |
| Total Equity | 81.36M | 59.49M | 51.03M | 33.02M | 24.88M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 209.73M | 174.1M | 177.84M | 120.81M | 41.38M |
| Total Liabilities | 131.51M | 132.74M | 125.43M | 96.19M | 8.36M |
| Total Equity | 78.22M | 41.36M | 52.41M | 24.62M | 33.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.49M | -29.55M | -32.47M | -50.47M | -11.45M |
| Investing | 4.96M | 29.47M | 29.6M | 49.14M | 14.7M |
| Financing | N/A | -11.66M | -11.66M | -11.87M | N/A |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 34.26M | -31.96M | -48.75M | -52.48M | -50.47M |
| Investing | -106.29M | 24.71M | 6.89M | 53.69M | 49.14M |
| Financing | 74.78M | 3.47M | 49.05M | -40k | -11.87M |
| Market Cap | 18.66M |
| Price to Earnings Ratio | 1.05 |
| Price to Sales Ratio | 0.29 |
| Price to Cash Ratio | 5.04 |
| Price to Book Ratio | 0.56 |
| Dividend Yield | - |
| Shares Outstanding | 6.66M |
| Average Volume (1 week) | 6.49k |
| Average Volume (1 Month) | 12.44k |
| 52 Week Change | -38.73% |
| 52 Week High | 4.97 |
| 52 Week Low | 2.30 |
| Spread (Intraday) | 0.14 (4.83%) |
| Company Name | MEI Pharma Inc |
| Address |
1209 orange st wilmington, delaware 19801 |
| Website | https://www.meipharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
